首页 / 院系成果 / 成果详情页

Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study 期刊论文

编号：

3109a79f-01ae-417b-8092-cf7ae53bcef6
作者：

He, Yiting#*^[1]Ou, Aihua^[1];Yang, Xiaobo^[1];Chen, Wei^[1];Fu, Liyuan^[1];Lu, Aiping^[2];Yan, Xiaoping^[3];Feng, Xinghua^[4];Su, Li(苏励)^[5]Song, Yuejin^[6];Zeng, Shengping^[7];Liu, Wei^[8];Qian, Xian^[9];Zhu, Wanhua^[10];Lao, Yingrong^[1];Xu, Weihua^[1];Wen, Zehuai^[1];He, Xiaohong^[1];Wang, Baojuan^[1];Chen, Gengxin^[1];Xue, Suqin^[1];
语种：

英文
期刊：

RHEUMATOLOGY INTERNATIONAL ISSN：0172-8172 2014 年 34 卷 12 期 (1647 - 1655) ; DEC
收录：
关键词：

Rheumatoid arthritis Therapy Traditional Chinese Medicine Western medicine Randomized Single-blind
摘要：

This study is designed to compare the efficacy and safety of traditional Chinese medicine (TCM) with western medicine (WM) in the management of rheumatoid arthritis (RA). This is a 24-week, randomized, multicenter, single-blind study comparing TCM with WM (as used in China) carried out between June 2002 and December 2004 in nine research centers in China, involving 489 patients. Patients were randomized to receive TCM (n = 247), MTX and SSZ (n = 242). MTX was started at a dose of 5 mg to a final dose of 7.5-15 mg weekly. The maintenance dose was 2.5-7.5 mg weekly. The starting dose of SSZ was 0.25 g bid, increasing by 0.25 g a day once a week to a final dose of 0.5-1 g qid. The maintenance dose was 0.5 g tid to qid. Primary end point was the proportion of patients with response according to the American College of Rheumatology 20 % improvement criteria (ACR20) at weeks 24. At 24 weeks, ACR20 responses were 53.0 % in TCM group and 66.5 % in WM group, (P < 0.001) at 24 weeks. ACR 50 responses were 31.6 % of TCM group and 42.6 % in WM group, (P = 0.01). ACR70 responses were 12.6 % in TCM group and 17.4 % in WM group, (P = 0.14). Side effects were observed more frequently in WM group. In this study, ACR20, ACR50 responses at 24 weeks were significantly better in the WM treated group, by intention to treat (ITT) and per protocol analysis. The ACR 70 response showed no significant difference between the two groups. TCM, while effective in treating RA, appears to be less effective than WM in controlling symptoms, but TCM is associated with fewer side effects.
推荐引用方式
GB/T 7714：

He Yi-ting,Ou Ai-hua,Yang Xiao-bo, et al. Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study [J].RHEUMATOLOGY INTERNATIONAL,2014,34(12):1647-1655.
APA：

He Yi-ting,Ou Ai-hua,Yang Xiao-bo,Chen Wei,&Xue Su-qin.(2014).Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study .RHEUMATOLOGY INTERNATIONAL,34(12):1647-1655.
MLA：

He Yi-ting, et al. "Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study" .RHEUMATOLOGY INTERNATIONAL 34,12(2014):1647-1655.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：99  下载次数：0

分享到：

浏览次数：99

下载次数：0

打印次数：0